Assessing AThrough Radiofrequency Transseptal Puncture System for Left Atrial Access
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 177 participants.
Also called NCT06386458
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 177 participants
- Sponsor
- Hangzhou NOYA MedTech Co. Ltm.
- Registry
-
NCT06386458
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06386458. Randomized; no masking; primary purpose treatment. Start 2022-07-08 (actual); primary completion 2023-05-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessing AThrough Radiofrequency Transseptal Puncture System for Left Atrial Access
- Condition
- Heart Diseases
- Condition
- Atrial Fibrillation
- Intervention (Device)
- AThrough radiofrequency transseptal puncture system
- Intervention (Device)
- Traditional mechanical transseptal puncture needle
- Lead sponsor
- Hangzhou NOYA MedTech Co. Ltm.
Record details
- Record id
cardio:ct-nct06386458- Content hash
1c572a2d9db243896f897c06b3cb86c099bf92961015d50dde06622208ca736b